Given the crosstalk between these pathways, we examined the inhibitory effects of these compounds, alone or in combination, on an aggressive TT MTC cell line harbouring the RET C634W activating mutation 15. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.